Evidence map›Paper›PMID 34585147›Full record

ArticleSTAR protocols2021

Determining effective drug concentrations for selection and counterselection genetics in

Nick Matinyan, Yezabel Gonzalez, Herman A Dierick, Koen J T Venken

Open access · goldAbstract read
In one paragraph

Article in STAR protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nick MatinyanVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Yezabel GonzalezVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Herman A DierickDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Koen J T VenkenVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Baylor College of Medicine · US

Funding

TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGYT32GM008231 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN · 1990 to 2019
$7.2M
Peptidergic regulation of aggression in Drosophila melanogasterR01MH107474 · NIMH · BAYLOR COLLEGE OF MEDICINE · PI DIERICK, HERMAN A · 2015 to 2019
$2.0M
The Drosophila Gene Tagging Project: Transgenes with Swappable Protein TagsR21HG006726 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI HOSKINS, ROGER ALLEN · 2012 to 2013
$486k
RESOLVING COMPLEX SYSTEMIC ENDOGENOUS EXPRESSION PATTERNS INTO SUBCELLULAR HIGH-RESOLUTION LOCALIZATIONR21OD022981 · OD · BAYLOR COLLEGE OF MEDICINE · PI VENKEN, KOEN JOZEF THEO · 2016 to 2017
$426k
NHGRI NIH HHS R21 HG006726NIGMS NIH HHS T32 GM008231NIH HHS R21 OD022981NIMH NIH HHS R01 MH107474
6 · The paper itself

Abstract

We recently integrated into fly genetics a set of four selection and two counterselection markers and their corresponding drugs that can be used individually or in combination. These markers eliminate the need to visually screen progeny. Before using these markers in new genetic backgrounds, effective selection/counterselection concentrations should be established for each marker/drug combination. This protocol describes how to set up, perform, and analyze a drug titration curve to determine the effective selection/counterselection drug concentrations for their corresponding markers. For complete details on the use and execution of this protocol, please refer to Matinyan et al., 2021.

Indexed as

Drosophila melanogasterAnimalsAnimals, Genetically ModifiedDrug ResistanceFemaleGenetic EngineeringGenetic MarkersMaleGenetic MarkersGeneticsModel organisms

Identifiers

PMID34585147
PMCPMC8458262
OpenAlexW3200600628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.